• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主动咨询检验科提高多发性骨髓瘤的诊断率:单中心 12 年经验。

Proactive consultation of laboratory medicine increased diagnostic rate of multiple myeloma: One single center's 12-year experience.

机构信息

Department of Clinical Pathology, Far Eastern Memorial Hospital, New Taipei, Taiwan.

Department of Nursing, Cardinal Tien Junior College of Healthcare and Management, Yilan, Taiwan.

出版信息

Medicine (Baltimore). 2024 Jun 7;103(23):e38523. doi: 10.1097/MD.0000000000038523.

DOI:10.1097/MD.0000000000038523
PMID:38847713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11155562/
Abstract

Multiple myeloma (MM) was one of the hardest cancers to diagnose because of numerous nonspecific symptoms, leading to diagnostic delay. Proactive consultation of laboratory medicine (PCLM) could help timely diagnosis of blood cancers, avoiding diagnostic delay. This study aimed to evaluate the effect of PCLM on diagnosis and outcomes in MM. This retrospective study was conducted in newly diagnosed MM patients from 2011 to 2022. Implementation of PCLM initiated in 2015 with a laboratory-oriented algorithm. The annual diagnostic rate, patient demographics, the time intervals from symptom onset to diagnosis and to treatment, and clinical outcomes were analyzed. A total of 134 patients were newly diagnosed during the study interval. The diagnostic rate increased from 4.65 ± 1.59 to 7.43 ± 1.52 per million patient-visits after implementation of PCLM. The median time interval from symptom onset to diagnosis was significantly shortened after implementation of PCLM (50 days with interquartile range [IQR]: 24-136 days vs 150 days with IQR: 41-385 days, P = .003). Besides, the 1-year survival was significantly higher in patients diagnosed as MM after implementation of PCLM (72.4% vs 51.7%, P = .035). Implementation of PCLM not only increased diagnostic rate of MM and improved outcomes, but also raise awareness for MM and promote multidisciplinary collaboration in healthcare.

摘要

多发性骨髓瘤(MM)是最难诊断的癌症之一,因为其存在许多非特异性症状,导致诊断延迟。主动咨询检验科(PCLM)可以帮助及时诊断血液系统癌症,避免诊断延迟。本研究旨在评估 PCLM 对 MM 诊断和预后的影响。本回顾性研究纳入了 2011 年至 2022 年间新诊断的 MM 患者。2015 年开始实施以实验室为导向的算法的 PCLM。分析了每年的诊断率、患者特征、从症状出现到诊断和治疗的时间间隔以及临床结局。在研究期间,共 134 名患者新诊断为 MM。实施 PCLM 后,诊断率从每百万患者就诊 4.65±1.59 例增加到 7.43±1.52 例。实施 PCLM 后,从症状出现到诊断的中位时间间隔显著缩短(50 天,四分位距[IQR]:24-136 天与 150 天,IQR:41-385 天,P=0.003)。此外,实施 PCLM 后诊断为 MM 的患者 1 年生存率显著提高(72.4% vs. 51.7%,P=0.035)。实施 PCLM 不仅提高了 MM 的诊断率和改善了结局,还提高了对 MM 的认识并促进了医疗保健中的多学科合作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b57/11155562/06e2b4e46daa/medi-103-e38523-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b57/11155562/b7d361ce7a81/medi-103-e38523-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b57/11155562/06e2b4e46daa/medi-103-e38523-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b57/11155562/b7d361ce7a81/medi-103-e38523-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b57/11155562/06e2b4e46daa/medi-103-e38523-g002.jpg

相似文献

1
Proactive consultation of laboratory medicine increased diagnostic rate of multiple myeloma: One single center's 12-year experience.主动咨询检验科提高多发性骨髓瘤的诊断率:单中心 12 年经验。
Medicine (Baltimore). 2024 Jun 7;103(23):e38523. doi: 10.1097/MD.0000000000038523.
2
Proactive Consultation by a Clinical Pathologist Prevents Diagnostic Delay in Hematological Malignancies.临床病理学家的主动会诊可预防血液系统恶性肿瘤的诊断延迟。
Asian Pac J Cancer Prev. 2016;17(3):1019-22. doi: 10.7314/apjcp.2016.17.3.1019.
3
Time to first consultation, diagnosis and treatment of TB among patients attending a referral hospital in Northwest, Ethiopia.在埃塞俄比亚西北部的一家转诊医院就诊的结核病患者的首次咨询、诊断和治疗时间。
BMC Infect Dis. 2014 Jan 10;14:19. doi: 10.1186/1471-2334-14-19.
4
Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial.多发性骨髓瘤的诊断途径及其与终末器官损害的关系:来自 Tackling Early Morbidity and Mortality in Myeloma(TEAMM)试验的分析。
Br J Haematol. 2021 Mar;192(6):997-1005. doi: 10.1111/bjh.17044. Epub 2020 Aug 15.
5
Time to diagnosis of symptomatic gastric and oesophageal cancer in the Netherlands: Where is the room for improvement?荷兰有症状的胃癌和食管癌的诊断时间:有哪些改进的空间?
United European Gastroenterol J. 2020 Jun;8(5):607-620. doi: 10.1177/2050640620917804. Epub 2020 Apr 6.
6
Understanding ethnic inequalities in cancer diagnostic intervals: a cohort study of patients presenting suspected cancer symptoms to GPs in England.了解癌症诊断间隔中的种族不平等:一项针对在英格兰向全科医生呈现疑似癌症症状患者的队列研究。
Br J Gen Pract. 2025 May 2;75(754):e333-e340. doi: 10.3399/BJGP.2024.0518. Print 2025 May.
7
Diagnostic delay in Canadian children with inflammatory bowel disease is more common in Crohn's disease and associated with decreased height.加拿大炎症性肠病患儿的诊断延误在克罗恩病中更为常见,且与身高降低有关。
Arch Dis Child. 2018 Apr;103(4):319-326. doi: 10.1136/archdischild-2017-313060. Epub 2017 Aug 9.
8
Myeloma: Patient accounts of their pathways to diagnosis.骨髓瘤:患者对其诊断途径的描述。
PLoS One. 2018 Apr 4;13(4):e0194788. doi: 10.1371/journal.pone.0194788. eCollection 2018.
9
Time intervals experienced between first symptom recognition and pathologic diagnosis of breast cancer in Addis Ababa, Ethiopia: a cross-sectional study.埃塞俄比亚亚的斯亚贝巴乳腺癌首次症状识别与病理诊断之间的时间间隔:一项横断面研究。
BMJ Open. 2019 Nov 11;9(11):e032228. doi: 10.1136/bmjopen-2019-032228.
10
Greenlandic patients with colorectal cancer: symptomatology, primary investigations and differences in diagnostic intervals between Nuuk and the rest of the country.格陵兰结直肠癌患者:症状学、初步检查以及努克与该国其他地区诊断间隔的差异。
Int J Circumpolar Health. 2017;76(1):1344086. doi: 10.1080/22423982.2017.1344086.

本文引用的文献

1
Emergency Medical Services in Taiwan: Past, Present, and Future.台湾的紧急医疗服务:过去、现在与未来。
J Acute Med. 2023 Sep;13(3):91-103. doi: 10.6705/j.jacme.202309_13(3).0001.
2
Transformation from zero tolerance to living with COVID-19 in New Taipei City, Taiwan. Experience of the FEMH "home-hotel-hospital" care model.台湾新北市从零容忍到与 COVID-19 共存的转变。FEMH“居家-旅馆-医院”护理模式的经验。
J Formos Med Assoc. 2024 Jan;123 Suppl 1:S39-S46. doi: 10.1016/j.jfma.2023.06.015. Epub 2023 Jun 22.
3
What causes delays in diagnosing blood cancers? A rapid review of the evidence.
导致血液癌诊断延误的原因是什么?证据的快速综述。
Prim Health Care Res Dev. 2023 Apr 11;24:e26. doi: 10.1017/S1463423623000129.
4
Clinical Performance of Rapid Antigen Tests for the Detection of SARS-CoV-2 Infection in the Emergency Department and Community: A Retrospective Study.急诊科和社区中快速抗原检测用于检测SARS-CoV-2感染的临床性能:一项回顾性研究
Can J Infect Dis Med Microbiol. 2022 Oct 6;2022:9447251. doi: 10.1155/2022/9447251. eCollection 2022.
5
The impact of the COVID-19 outbreak on activation of the massive transfusion protocol in the emergency department.新型冠状病毒肺炎疫情对急诊科大量输血方案启动的影响。
Vox Sang. 2022 May;117(5):729-732. doi: 10.1111/vox.13238. Epub 2022 Jan 4.
6
The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.血液学和生化学参数在 2019 年冠状病毒病患者急诊科的预测和预后作用。
Chin J Physiol. 2021 Nov-Dec;64(6):306-311. doi: 10.4103/cjp.cjp_77_21.
7
Hyperviscosity syndrome in IgA multiple myeloma.IgA 多发性骨髓瘤中的高黏滞综合征
QJM. 2022 Jan 21;115(1):30-31. doi: 10.1093/qjmed/hcab175.
8
Confirmed Cryoglobulinemia and Hyperviscosity Syndrome Secondary to Multiple Myeloma-IgA Kappa from Routine Blood Test: a Case Report.通过常规血液检查确诊的继发于多发性骨髓瘤-IgA κ型的冷球蛋白血症和高黏滞综合征:一例报告
Clin Lab. 2020 Jun 1;66(6). doi: 10.7754/Clin.Lab.2019.191127.
9
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.意大利 COVID-19 时代心肌梗死住院人数减少。
Eur Heart J. 2020 Jun 7;41(22):2083-2088. doi: 10.1093/eurheartj/ehaa409.
10
The Untold Toll - The Pandemic's Effects on Patients without Covid-19.未知的代价——疫情对非新冠患者的影响
N Engl J Med. 2020 Jun 11;382(24):2368-2371. doi: 10.1056/NEJMms2009984. Epub 2020 Apr 17.